These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

338 related items for PubMed ID: 21129393

  • 1. Co-encapsulation of antigen and Toll-like receptor ligand in cationic liposomes affects the quality of the immune response in mice after intradermal vaccination.
    Bal SM, Hortensius S, Ding Z, Jiskoot W, Bouwstra JA.
    Vaccine; 2011 Jan 29; 29(5):1045-52. PubMed ID: 21129393
    [Abstract] [Full Text] [Related]

  • 2. Adjuvanted, antigen loaded N-trimethyl chitosan nanoparticles for nasal and intradermal vaccination: adjuvant- and site-dependent immunogenicity in mice.
    Bal SM, Slütter B, Verheul R, Bouwstra JA, Jiskoot W.
    Eur J Pharm Sci; 2012 Mar 12; 45(4):475-81. PubMed ID: 22009113
    [Abstract] [Full Text] [Related]

  • 3. Co-encapsulation of an antigen and CpG oligonucleotides into PLGA microparticles by TROMS technology.
    San Román B, Irache JM, Gómez S, Tsapis N, Gamazo C, Espuelas MS.
    Eur J Pharm Biopharm; 2008 Sep 12; 70(1):98-108. PubMed ID: 18501572
    [Abstract] [Full Text] [Related]

  • 4. Adjuvant effect of cationic liposomes and CpG depends on administration route.
    Slütter B, Bal SM, Ding Z, Jiskoot W, Bouwstra JA.
    J Control Release; 2011 Sep 05; 154(2):123-30. PubMed ID: 21315779
    [Abstract] [Full Text] [Related]

  • 5. Administration routes affect the quality of immune responses: A cross-sectional evaluation of particulate antigen-delivery systems.
    Mohanan D, Slütter B, Henriksen-Lacey M, Jiskoot W, Bouwstra JA, Perrie Y, Kündig TM, Gander B, Johansen P.
    J Control Release; 2010 Nov 01; 147(3):342-9. PubMed ID: 20727926
    [Abstract] [Full Text] [Related]

  • 6. Co-delivery of ovalbumin and CpG motifs into microparticles protected sensitized mice from anaphylaxis.
    San Román B, Irache JM, Gómez S, Gamazo C, Espuelas S.
    Int Arch Allergy Immunol; 2009 Nov 01; 149(2):111-8. PubMed ID: 19127067
    [Abstract] [Full Text] [Related]

  • 7. Efficient induction of immune responses through intradermal vaccination with N-trimethyl chitosan containing antigen formulations.
    Bal SM, Slütter B, van Riet E, Kruithof AC, Ding Z, Kersten GF, Jiskoot W, Bouwstra JA.
    J Control Release; 2010 Mar 19; 142(3):374-83. PubMed ID: 19932723
    [Abstract] [Full Text] [Related]

  • 8. Immunological responses after immunisation of mice with microparticles containing antigen and single stranded RNA (polyuridylic acid).
    Westwood A, Elvin SJ, Healey GD, Williamson ED, Eyles JE.
    Vaccine; 2006 Mar 10; 24(11):1736-43. PubMed ID: 16278038
    [Abstract] [Full Text] [Related]

  • 9. Liposome-encapsulated CpG oligodeoxynucleotides as a potent adjuvant for inducing type 1 innate immunity.
    Suzuki Y, Wakita D, Chamoto K, Narita Y, Tsuji T, Takeshima T, Gyobu H, Kawarada Y, Kondo S, Akira S, Katoh H, Ikeda H, Nishimura T.
    Cancer Res; 2004 Dec 01; 64(23):8754-60. PubMed ID: 15574787
    [Abstract] [Full Text] [Related]

  • 10. Enhanced transcutaneous immunization via dissolving microneedle array loaded with liposome encapsulated antigen and adjuvant.
    Guo L, Chen J, Qiu Y, Zhang S, Xu B, Gao Y.
    Int J Pharm; 2013 Apr 15; 447(1-2):22-30. PubMed ID: 23410987
    [Abstract] [Full Text] [Related]

  • 11. An indispensable role of type-1 IFNs for inducing CTL-mediated complete eradication of established tumor tissue by CpG-liposome co-encapsulated with model tumor antigen.
    Wakita D, Chamoto K, Zhang Y, Narita Y, Noguchi D, Ohnishi H, Iguchi T, Sakai T, Ikeda H, Nishimura T.
    Int Immunol; 2006 Mar 15; 18(3):425-34. PubMed ID: 16415100
    [Abstract] [Full Text] [Related]

  • 12. Co-administration of polyphosphazenes with CpG oligodeoxynucleotides strongly enhances immune responses in mice immunized with Hepatitis B virus surface antigen.
    Mutwiri G, Benjamin P, Soita H, Babiuk LA.
    Vaccine; 2008 May 23; 26(22):2680-8. PubMed ID: 18430493
    [Abstract] [Full Text] [Related]

  • 13. Effect of sublingual administration with a native or denatured protein allergen and adjuvant CpG oligodeoxynucleotides or cholera toxin on systemic T(H)2 immune responses and mucosal immunity in mice.
    Huang CF, Wang CC, Wu TC, Chu CH, Peng HJ.
    Ann Allergy Asthma Immunol; 2007 Nov 23; 99(5):443-52. PubMed ID: 18051215
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Immunostimulatory and antigen delivery properties of liposomes made up of total polar lipids from non-pathogenic bacteria leads to efficient induction of both innate and adaptive immune responses.
    Faisal SM, Chen JW, McDonough SP, Chang CF, Teng CH, Chang YF.
    Vaccine; 2011 Mar 16; 29(13):2381-91. PubMed ID: 21300103
    [Abstract] [Full Text] [Related]

  • 16. Orally administered OVA/CpG-ODN induces specific mucosal and systemic immune response in young and aged mice.
    Alignani D, Maletto B, Liscovsky M, Rópolo A, Morón G, Pistoresi-Palencia MC.
    J Leukoc Biol; 2005 Jun 16; 77(6):898-905. PubMed ID: 15758079
    [Abstract] [Full Text] [Related]

  • 17. Modulation of ovalbumin-induced Th2 responses by second-generation immunomodulatory oligonucleotides in mice.
    Zhu FG, Kandimalla ER, Yu D, Tang JX, Agrawal S.
    Int Immunopharmacol; 2004 Jul 16; 4(7):851-62. PubMed ID: 15182725
    [Abstract] [Full Text] [Related]

  • 18. The synthetic TLR2 agonist BPPcysMPEG leads to efficient cross-priming against co-administered and linked antigens.
    Prajeeth CK, Jirmo AC, Krishnaswamy JK, Ebensen T, Guzman CA, Weiss S, Constabel H, Schmidt RE, Behrens GM.
    Eur J Immunol; 2010 May 16; 40(5):1272-83. PubMed ID: 20213735
    [Abstract] [Full Text] [Related]

  • 19. Self-assembling CpG DNA nanoparticles for efficient antigen delivery and immunostimulation.
    Rattanakiat S, Nishikawa M, Takakura Y.
    Eur J Pharm Sci; 2012 Sep 29; 47(2):352-8. PubMed ID: 22771546
    [Abstract] [Full Text] [Related]

  • 20. Time course study of the antigen-specific immune response to a PLGA microparticle vaccine formulation.
    Wang Q, Tan MT, Keegan BP, Barry MA, Heffernan MJ.
    Biomaterials; 2014 Sep 29; 35(29):8385-93. PubMed ID: 24986256
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 17.